(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.04%) $78.08
(0.61%) $2.16
(-0.21%) $2 303.80
(0.13%) $26.73
(-0.69%) $958.60
(0.01%) $0.929
(-0.09%) $10.86
(-0.02%) $0.797
(0.00%) $91.45
15.79% $ 0.660
Live Chart Being Loaded With Signals
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease...
Stats | |
---|---|
Volumen de hoy | 9 553.00 |
Volumen promedio | 14 805.00 |
Capitalización de mercado | 2.72M |
EPS | $-0.0311 ( 2024-04-24 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.75 |
ATR14 | $0.0150 (2.27%) |
Regen BioPharma, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Regen BioPharma, Inc. Finanzas
Annual | 2023 |
Ingresos: | $236 560 |
Beneficio Bruto: | $176 560 (74.64 %) |
EPS: | $0.290 |
FY | 2023 |
Ingresos: | $236 560 |
Beneficio Bruto: | $176 560 (74.64 %) |
EPS: | $0.290 |
FY | 2022 |
Ingresos: | $235 517 |
Beneficio Bruto: | $185 517 (78.77 %) |
EPS: | $1.750 |
FY | 2021 |
Ingresos: | $171 194 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.00225 |
Financial Reports:
No articles found.
Regen BioPharma, Inc.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico